NCT/Study#
N/A /
AMYLOID-BIOMARKERS
Prognostic impact of cardiac and other biomarkers in patients with light chain amyloidosis
DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
